Literature DB >> 24271348

Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City.

D C Des Jarlais1, K Arasteh, C McKnight, J Feelemyer, H Hagan, H L F Cooper, D C Perlman.   

Abstract

Examine long term sexual risk behaviors among persons who inject drugs (PWID) in New York City following implementation of "combined" prevention programming, including condom social marketing. Quantitative interviews and human immunodeficiency virus (HIV) testing were conducted among PWID entering Beth Israel Medical Center drug treatment programs 1990-2012. Data were analyzed by four time periods corresponding to the cumulative implementation of HIV prevention interventions. 7,132 subjects were recruited from 1990 to 2012; little change in sexual behavior occurred among HIV seronegative subjects, while HIV seropositive subjects reported significant decreases in being sexually active and significant increases in consistent condom use. HIV transmission risk (being HIV positive and engaging in unprotected sex) declined from 14 % in 1990-1995 to 2 % in 2007-2012 for primary sexual partners and from 6 to 1 % for casual partners. Cumulative implementation of combined prevention programming for PWID was associated with substantial decreases in sexual risk behavior among HIV seropositives.

Entities:  

Mesh:

Year:  2014        PMID: 24271348      PMCID: PMC3947424          DOI: 10.1007/s10461-013-0664-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  28 in total

1.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

2.  Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison.

Authors:  Paul Sendziuk
Journal:  Can Bull Med Hist       Date:  2007

3.  The NYC Condom: use and acceptability of New York City's branded condom.

Authors:  Ryan C Burke; Juliet Wilson; Kyle T Bernstein; Nicholas Grosskopf; Christopher Murrill; Blayne Cutler; Monica Sweeney; Elizabeth M Begier
Journal:  Am J Public Health       Date:  2009-10-15       Impact factor: 9.308

4.  Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Holly Hagan; Sara Beatrice; Lou Smith; Judith Wethers; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

5.  Sexual harm reduction practices of HIV-seropositive gay and bisexual men: serosorting, strategic positioning, and withdrawal before ejaculation.

Authors:  Jeffrey T Parsons; Eric W Schrimshaw; Richard J Wolitski; Perry N Halkitis; David W Purcell; Colleen C Hoff; Cynthia A Gómez
Journal:  AIDS       Date:  2005-04       Impact factor: 4.177

6.  Declining HIV/AIDS mortality in New York City.

Authors:  M A Chiasson; L Berenson; W Li; S Schwartz; T Singh; S Forlenza; B A Mojica; M A Hamburg
Journal:  J Acquir Immune Defic Syndr       Date:  1999-05-01       Impact factor: 3.731

Review 7.  Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.

Authors:  France Lert; Michel D Kazatchkine
Journal:  Int J Drug Policy       Date:  2007-07-17

8.  Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Holly Hagan; Courtney McKnight; David C Perlman; Samuel R Friedman
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

9.  HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Lucia V Torian; Sara Beatice; Salaam Semaan; Samuel R Friedman
Journal:  Drug Alcohol Depend       Date:  2010-02-16       Impact factor: 4.492

10.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Authors:  Charlotte Van Den Berg; Colette Smit; Giel Van Brussel; Roel Coutinho; Maria Prins
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

View more
  13 in total

1.  A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City.

Authors:  Don C Des Jarlais; Courtney McKnight; Kamyar Arasteh; Jonathan Feelemyer; David C Perlman; Holly Hagan; Emily F Dauria; Hannah L F Cooper
Journal:  Subst Use Misuse       Date:  2014-02-06       Impact factor: 2.164

2.  Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.

Authors:  Ashly E Jordan; Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Denis Nash; David C Perlman
Journal:  Drug Alcohol Depend       Date:  2015-04-13       Impact factor: 4.492

3.  Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?

Authors:  David C Perlman; Don C Des Jarlais; Jonathan Feelemyer
Journal:  J Addict Dis       Date:  2015

4.  State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness.

Authors:  Heidi Bramson; Don C Des Jarlais; Kamyar Arasteh; Ann Nugent; Vivian Guardino; Jonathan Feelemyer; Derek Hodel
Journal:  J Public Health Policy       Date:  2015-01-15       Impact factor: 2.222

5.  Sexual risk behaviors and STDs among persons who inject drugs: A national study.

Authors:  Kathryn A Brookmeyer; Laura T Haderxhanaj; Matthew Hogben; Jami Leichliter
Journal:  Prev Med       Date:  2019-07-15       Impact factor: 4.018

6.  Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?

Authors:  Don Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Holly Hagan; Hannah Cooper; Aimee Campbell; Susan Tross; David Perlman
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

Review 7.  Harm reduction in the USA: the research perspective and an archive to David Purchase.

Authors:  Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2017-07-26

8.  Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.

Authors:  D C Des Jarlais; H L F Cooper; K Arasteh; J Feelemyer; C McKnight; Z Ross
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

9.  Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history.

Authors:  D C Des Jarlais; C McKnight; K Arasteh; J Feelemyer; Zev Ross; H L F Cooper
Journal:  Harm Reduct J       Date:  2019-09-02

10.  Women's Decision-Making about PrEP for HIV Prevention in Drug Treatment Contexts.

Authors:  Yilu Qin; Carolina Price; Ronnye Rutledge; Lisa Puglisi; Lynn M Madden; Jaimie P Meyer
Journal:  J Int Assoc Provid AIDS Care       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.